Sentences with phrase «gynecologic oncology group»

These include studies that are sponsored by the Eastern Cooperative Oncology Group (ECOG), the Gynecologic Oncology Group, the AIDS Malignancy Consortium and Accelerated Clinical Oncology Research Network (ACORN).

The Gynecologic Oncology Group study is sponsored by vaccine developers, Advaxis, Inc., a Princeton, New Jersey - based company that focuses on immunotherapies to combat cancer.

NRG brings together three former clinical trial groups from the NCI Cooperative Group program: the National Surgical Adjuvant Breast and Bowel Project, Radiation Therapy Oncology Group and the Gynecologic Oncology Group.

Previous research (the Gynecologic Oncology Group's GOG181B trial) has suggested that trastuzumab is inactive in HER2 / neu - expressing endometrial carcinomas, and in the current study, nearly half of the participants «ultimately did not have tumoral HER2 / neu gene amplification,» Dr. Santin said.

Women with Stage III ovarian cancer given a combination of intravenous and intraperitoneal chemotherapy following surgical debulking of tumor had a median survival nearly 16 months longer than women who received IV chemotherapy alone, according to a study published conducted by the Gynecologic Oncology Group (GOG), a National Cancer Institute - supported research network, in the January 5, 2006 issue of the New England Journal of Medicine.

Based on these results, two phase 3 trials are being planned for platinum - sensitive and platinum - resistant ovarian cancer patients by one of NCI's new National Cancer Trial Network Groups, the NRG Oncology Group (formerly 3 cooperative groups: the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG).

This study, conducted by the Gynecologic Oncology Group, a cooperative group funded by the National Cancer Institute, was the second to test bevacizumab under these conditions (first chemotherapy for platinum - sensitive recurrence), a use for which bevacizumab is not currently approved by the Food and Drug Administration.

In the Phase II clinical trial, Dr. Miller and colleagues in the National Cancer Institute - supported Gynecologic Oncology Group found that in patients who had not received prior chemotherapy, the combination cocktail had a 31 percent response rate for up to 7 months, and an overall survival of 12 months.

TRINOVA - 2 is evaluating pegylated liposomal doxorubicin in combination with either placebo or trebananib in previously treated patients with ovarian cancer while TRINOVA - 3, also known as ENGOT - Ov2 and Gynecologic Oncology Group — 3001, is studying the use of trebananib in front - line treatment adding it to carboplatin / paclitaxel.

Not exact matches

Today's guidance, written by a group of cervical cancer screening experts led by University of Alabama at Birmingham gynecologic oncologist Warner Huh, M.D., is being published simultaneously in the journals Gynecologic Oncology, Obstetrics & Gynecology, and the Journal of Lower Genital Tract Disease under the title «Use of Primary High Risk Human Papillomavirus Testing for Cervical Cancer Screening: Interim Clinical Guidagynecologic oncologist Warner Huh, M.D., is being published simultaneously in the journals Gynecologic Oncology, Obstetrics & Gynecology, and the Journal of Lower Genital Tract Disease under the title «Use of Primary High Risk Human Papillomavirus Testing for Cervical Cancer Screening: Interim Clinical GuidaGynecologic Oncology, Obstetrics & Gynecology, and the Journal of Lower Genital Tract Disease under the title «Use of Primary High Risk Human Papillomavirus Testing for Cervical Cancer Screening: Interim Clinical Guidance.»

Brian M. Slomovitz, M.D., co-leader of the Gynecologic Cancers Site Disease Group at Sylvester Comprehensive Cancer Center, received the 2018 Presidential Abstract Award from the Society for Gynecologic Oncology on March 24 during the group's Annual Meeting on Women's Cancer in New OrlGroup at Sylvester Comprehensive Cancer Center, received the 2018 Presidential Abstract Award from the Society for Gynecologic Oncology on March 24 during the group's Annual Meeting on Women's Cancer in New Orlgroup's Annual Meeting on Women's Cancer in New Orleans.